Is 0% Expense Ratio really a 0% Expense Ratio?

Barkha Rani Aug 12, 2018

Market View

Trade tensions between China and the US have continued with the recent news that Beijing announced the most recent round of US tariffs with its own. The Chinese Ministry announced a 25% charge on $16 million worth of US goods. So far, China has picked out 333 goods including vehicles, recyclables and fiber optical cables. A tweet over human rights ignited a feud between Saudi Arabia and Canada, which has now escalated into a big diplomatic rift between the two countries. The Canadian dollar was 76.18 cents U.S. The week ended with the TSX and S&P500 flat. 

All but two of the TSX subgroups slipped this week, with the declines in consumer discretionary (3.4%), consumer staples (2.3%), energy (1.7%), and utility (1.3%).  Technology was up 2.1% and health care 1.4%. Pretium Resources jumped 19% and Ritchie Bros was up 10.6% after reporting strong second-quarter results. Nuvista Energy fell 8.7% after acquiring assets in the Pipestone area of Northwest Alberta. Uni-Select Inc slipped 4.7% after reporting second-quarter results, and Magna International fell 7.8% after lowering its full-year production forecast for North America. The most heavily traded shares by volume were Osisko Mining, Bombardier and Aurora Cannabis.

5 from 5i

Here are five reads we found interesting last week:

-FAANG is not the only catalyst for the market

-Have we hyped up our expectations from ETFs?

-What a 0% Expense Ratio funds really mean.  

-How is Apple targeting one of the fastest growing economies, India

-Does it matter for investors, what the Fed does?

ICYMI at 5i Research:

-Peter Hodson, Founder and Head of Research at 5i Research, was on BNN Bloomberg discussing his top picks

-Meet the FAANGs of the TSX

- Answers to the questions from anxious investors

- The dangers of defining yourself as a growth or value investor.

- What do you define risk as?

See our previous Five from 5i here:

How to play a flattening yield curve

0 comments

Comments

Login to post a comment.

No comments have been posted yet.